Clinical Trials Directory

Trials / Completed

CompletedNCT01881620

PET Enhanced CT Scan Performance in Cancer

PET / Enhanced CT Scan Performance in Cancer (Positron Emission Tomography Combined With Computed Tomography or Vascular Contrast CT Scan). COMBI TEP Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
109 (actual)
Sponsor
Institut Bergonié · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypothesis: The investigators would like to demonstrate that diagnosis performance of PET/CT scan without and with contrast agent (COMBI TEP), are equivalent or better than those of PET/ non enhanced CT scan (PET scan) associated with an enhanced CT scan. This research project is a pilot study given the few available data concerning this imaging exam reproducibility. This study is a prospective single center study.

Detailed description

Hypothesis: We would like to demonstrate that diagnosis performance of PET/CT scan without and with contrast agent (COMBI TEP), are equivalent or better than those of PET/ non enhanced CT scan (PET scan) associated with an enhanced CT scan. This research project is a pilot study given the few available data concerning this imaging exam reproducibility. This study allows us to assess the feasibility of such a large-scale study, but also to evaluate COMBI TEP performance. From these estimates, we can then consider a comparative study to evaluate the performance of COMBI PET. This study is a prospective single center study.

Conditions

Interventions

TypeNameDescription
DEVICECOMBI TEP : PET / enhanced CT scandiagnostic imaging exam

Timeline

Start date
2010-03-19
Primary completion
2012-07-19
Completion
2015-07-15
First posted
2013-06-19
Last updated
2024-11-18
Results posted
2019-10-01

Source: ClinicalTrials.gov record NCT01881620. Inclusion in this directory is not an endorsement.

PET Enhanced CT Scan Performance in Cancer (NCT01881620) · Clinical Trials Directory